Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Yabe

Showing results (1-10 of 274) with videos related to

Pageof 28
Sort By:
Diabetology International|July 3, 2025
Incretins: mechanistic insights, clinical realities, and translational perspectives in type 2 diabetes and obesityDaisuke Yabe
JMA Journal|August 8, 2024
Harnessing the Therapeutic Potential of SGLT2 Inhibitors in Type 2 Diabetes: Challenges and OpportunitiesDaisuke Yabe
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 21, 2011
[Immunoassays for the incretin hormones GIP and GLP-1]Daisuke Yabe, Yutaka Seino
Journal of Diabetes Investigation|September 10, 2016
Cardiovascular safety trials of incretin-based drugs: What do they mean?Daisuke Yabe, Yutaka Seino
Progress in Biophysics and Molecular Biology|August 9, 2011
Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservationDaisuke Yabe, Yutaka Seino
Clinical Medicine Insights. Endocrinology and Diabetes|August 11, 2012
Liraglutide in adults with type 2 diabetes: global perspective on safety, efficacy and patient preferenceDaisuke Yabe, Yutaka Seino
Expert Opinion on Pharmacotherapy|March 21, 2014
Alogliptin benzoate for the treatment of type 2 diabetesYutaka Seino, Daisuke Yabe
Journal of Diabetes Investigation|November 21, 2014
Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?Daisuke Yabe, Yutaka Seino
Nutrients|June 10, 2020
The Role of Metagenomics in Precision NutritionKatsumi Iizuka, Daisuke Yabe
European Thyroid Journal|January 10, 2025
Best practices in the management of thyroid dysfunction induced by immune checkpoint inhibitorsIchiro Yamauchi, Daisuke Yabe
Pageof 28

Showing results (1-10 of 274) with videos related to

Sort By:
Pageof 28
Diabetology International|July 3, 2025
Incretins: mechanistic insights, clinical realities, and translational perspectives in type 2 diabetes and obesityDaisuke Yabe
JMA Journal|August 8, 2024
Harnessing the Therapeutic Potential of SGLT2 Inhibitors in Type 2 Diabetes: Challenges and OpportunitiesDaisuke Yabe
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 21, 2011
[Immunoassays for the incretin hormones GIP and GLP-1]Daisuke Yabe, Yutaka Seino
Journal of Diabetes Investigation|September 10, 2016
Cardiovascular safety trials of incretin-based drugs: What do they mean?Daisuke Yabe, Yutaka Seino
Progress in Biophysics and Molecular Biology|August 9, 2011
Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservationDaisuke Yabe, Yutaka Seino
Clinical Medicine Insights. Endocrinology and Diabetes|August 11, 2012
Liraglutide in adults with type 2 diabetes: global perspective on safety, efficacy and patient preferenceDaisuke Yabe, Yutaka Seino
Expert Opinion on Pharmacotherapy|March 21, 2014
Alogliptin benzoate for the treatment of type 2 diabetesYutaka Seino, Daisuke Yabe
Journal of Diabetes Investigation|November 21, 2014
Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?Daisuke Yabe, Yutaka Seino
Nutrients|June 10, 2020
The Role of Metagenomics in Precision NutritionKatsumi Iizuka, Daisuke Yabe
European Thyroid Journal|January 10, 2025
Best practices in the management of thyroid dysfunction induced by immune checkpoint inhibitorsIchiro Yamauchi, Daisuke Yabe
Pageof 28